Global Sexually Transmitted Infections (STIs) Market Forecast 2024-2033 – Market Size, Drivers, Trends, And Competitors

December 20, 2023 05:15 PM GMT | By EIN Presswire
 Global Sexually Transmitted Infections (STIs) Market Forecast 2024-2033 – Market Size, Drivers, Trends, And Competitors
Image source: EIN Presswire

LANDON, GREATER LANDON, UK, December 20, 2023 /EINPresswire.com/ -- Business Research Company's Year-End Special: Get a 33% discount on Opportunities and Strategies Reports and a 25% discount on Global Market Reports.

The Business Research Company’s “Sexually Transmitted Infections (STIs) Global Market Report 2024 is a comprehensive source of information that covers every facet of the market. As per TBRC’s market forecast, the sexually transmitted infections (stis) market size is predicted to reach The sexually transmitted infections (stis) market size has grown rapidly in recent years. It will grow from $56.17 billion in 2023 to $63.69 billion in 2024 at a compound annual growth rate (CAGR) of 13.4%. The growth in the historic period can be attributed to behavioral factors, education and awareness, healthcare access, antibiotic development.The sexually transmitted infections (stis) market size is expected to see rapid growth in the next few years. It will grow to $100.66 billion in 2028 at a compound annual growth rate (CAGR) of 12.1%.

The growth in the sexually transmitted infections (stis) market is due to the surge in government initiatives for spreading awareness of sexually transmitted infections. North America region is expected to hold the largest sexually transmitted infections (stis) market share. Major players in the sexually transmitted infections (stis) market include Pfizer Inc., Johnson & Johnson, Roche Holdings AG, Merck & Co Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb.

Sexually Transmitted Infections (STIs) Market Segments

• By Type: Human Immunodeficiency Virus (HIV), Human Papilloma Virus (HPV), Gonorrhea, Syphilis, Other Types
• By Treatment: Antibiotics, Antiviral
• By Location Of Testing: Laboratory Testing, Point-Of-Care (POC) Testing
• By Route Of Administration: Oral, Parenteral, Other Route Of Administration
• By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users
• By Geography: The global sexually transmitted infections (stis) market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Learn More On The Market By Requesting A Free Sample (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=13047&type=smp

High treatments costs are negatively affecting the growth of the sexually transmitted infections market during forecast period. High treatment costs can exacerbate health disparities, as individuals with limited financial resources may face greater barriers to accessing timely and effective STI care. This can contribute to inequalities in STI prevalence and outcomes. For instance, according to the American Hospital Association, a professional organization, over the year leading up to February 2022, hospital prices saw a rise of 2.1%. Therefore, the high cost of treatment is hindering the growth of the sexually transmitted infections market.

Read More On The Sexually Transmitted Infections (STIs) Global Market Report At:
https://www.thebusinessresearchcompany.com/report/sexually-transmitted-infections-stis-global-market-report

The Table Of Content For The Market Report Include:

1. Executive Summary
2. Sexually Transmitted Infections (STIs) Market Characteristics
3. Sexually Transmitted Infections (STIs) Market Trends And Strategies
4. Sexually Transmitted Infections (STIs) Market – Macro Economic Scenario
5. Sexually Transmitted Infections (STIs) Market Size And Growth
……
27. Sexually Transmitted Infections (STIs) Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Market
29. Sexually Transmitted Infections (STIs) Market Future Outlook and Potential Analysis
30. Appendix

Browse Through More Similar Reports By The Business Research Company:

Hormonal Contraceptives Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Infertility Treatment Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/infertility-treatment-global-market-report

STD Diagnostics Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/std-diagnostics-global-market-report

Contact Information
The Business Research Company: https://www.thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]

Check out our:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
Twitter
LinkedIn


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (Kalkine Media, we or us) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalised advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.


Sponsored Articles


Investing Ideas

Previous Next